Atlas Trials

A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients

Clinical trial NCT01224028 · COMPLETED

Trial details

NCT number
NCT01224028
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
IgA Nephropathy
Start date
2010-11-01
Primary completion
2011-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.